Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis

[1]  M. Pinzani.  Fibrosis : Pathophysiology , Diagnosis and Treatment , 2015 .

[2]  T. Iwama,et al.  Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia–reperfusion injury , 2014, Neuroscience.

[3]  C. Argmann,et al.  Lysosomal Stress in Obese Adipose Tissue Macrophages Contributes to MITF-Dependent Gpnmb Induction , 2014, Diabetes.

[4]  C. Hellerbrand,et al.  Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. , 2014, Best practice & research. Clinical gastroenterology.

[5]  K. Ariizumi,et al.  The DC-HIL/Syndecan-4 Pathway Regulates Autoimmune Responses through Myeloid-Derived Suppressor Cells , 2014, The Journal of Immunology.

[6]  E. Albano,et al.  Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH , 2014, Hepatology.

[7]  A. Forero,et al.  Management of Metastatic Breast Cancer with Second-Generation Antibody–Drug Conjugates: Focus on Glembatumumab Vedotin (CDX-011, CR011-vcMMAE) , 2014, BioDrugs.

[8]  R. Men,et al.  Blockage of TRPM7 channel induces hepatic stellate cell death through endoplasmic reticulum stress-mediated apoptosis. , 2014, Life sciences.

[9]  Taro Ohkido,et al.  NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane , 2013, Neuroscience Letters.

[10]  S. Werner,et al.  Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. , 2013, Journal of hepatology.

[11]  K. Ariizumi,et al.  The DC‐HIL ligand syndecan‐4 is a negative regulator of T‐cell allo‐reactivity responsible for graft‐versus‐host disease , 2013, Immunology.

[12]  G. Svegliati-Baroni,et al.  Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[13]  M. Abraham,et al.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis , 2012, Hepatology.

[14]  G. Sobue,et al.  The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis , 2012, Scientific Reports.

[15]  P. Li,et al.  Caveosomal Oxidative Stress Causes Src-p21ras Activation and Lysine 63 TRAF6 Protein Polyubiquitination in Iron-induced M1 Hepatic Macrophage Activation* , 2012, The Journal of Biological Chemistry.

[16]  Michael Charlton,et al.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.

[17]  S. Popoff,et al.  Homeodomain transcription factors regulate BMP‐2‐induced osteoactivin transcription in osteoblasts , 2012, Journal of cellular physiology.

[18]  L. Devi,et al.  Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis , 2011, Cell Death and Disease.

[19]  F. Pépin,et al.  ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties , 2010, PloS one.

[20]  K. Ariizumi,et al.  DC-HIL/glycoprotein Nmb promotes growth of melanoma in mice by inhibiting the activation of tumor-reactive T cells. , 2010, Cancer research.

[21]  M. Hallett,et al.  Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer , 2010, Clinical Cancer Research.

[22]  K. Ariizumi,et al.  The DC‐HIL/syndecan‐4 pathway inhibits human allogeneic T‐cell responses , 2009, European journal of immunology.

[23]  A. Selim.  Osteoactivin bioinformatic analysis: prediction of novel functions, structural features, and modes of action. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[24]  Michael G. Anderson,et al.  Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. , 2008, Experimental cell research.

[25]  K. Kishi,et al.  Osteoactivin fragments produced by ectodomain shedding induce MMP‐3 expression via ERK pathway in mouse NIH‐3T3 fibroblasts , 2007, FEBS letters.

[26]  P. Siegel,et al.  Osteoactivin/HGFIN: is it a tumor suppressor or mediator of metastasis in breast cancer? , 2007, Breast Cancer Research.

[27]  F. Pépin,et al.  Osteoactivin Promotes Breast Cancer Metastasis to Bone , 2007, Molecular Cancer Research.

[28]  D. Hume,et al.  Gpnmb Is Induced in Macrophages by IFN-γ and Lipopolysaccharide and Acts as a Feedback Regulator of Proinflammatory Responses1 , 2007, The Journal of Immunology.

[29]  K. Ariizumi,et al.  DC-HIL is a negative regulator of T lymphocyte activation. , 2007, Blood.

[30]  K. Nagata,et al.  Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. , 2007, Biochemical and biophysical research communications.

[31]  Michael G. Anderson,et al.  Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma , 2006, BMC Biology.

[32]  Eijiro Watanabe,et al.  Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[34]  G. Ramadori,et al.  Expression of osteoactivin in rat and human liver and isolated rat liver cells. , 2005, Journal of hepatology.

[35]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[36]  K. Nagata,et al.  Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. , 2003, Journal of hepatology.

[37]  D. Bigner,et al.  Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model* , 2003, The Journal of Biological Chemistry.

[38]  G. Yehia,et al.  Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P , 2003, Regulatory Peptides.

[39]  K. Ariizumi,et al.  Molecular Cloning of a Dendritic Cell-associated Transmembrane Protein, DC-HIL, That Promotes RGD-dependent Adhesion of Endothelial Cells through Recognition of Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[40]  H. Ohno,et al.  Cell Surface Expression of Calnexin, a Molecular Chaperone in the Endoplasmic Reticulum* , 2000, The Journal of Biological Chemistry.

[41]  H. Makino,et al.  Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. , 2000, Journal of lipid research.

[42]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[43]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[44]  A. Singer,et al.  The molecular chaperone calnexin is expressed on the surface of immature thymocytes in association with clonotype‐independent CD3 complexes. , 1995, The EMBO journal.

[45]  N. Ajubi,et al.  nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenografts , 1995, International journal of cancer.

[46]  S. Auerbach,et al.  Impact of ethnicity , 1985 .

[47]  S. Popoff,et al.  Functional roles of osteoactivin in normal and disease processes. , 2010, Critical reviews in eukaryotic gene expression.

[48]  J. Wada.  Vaspin: a novel serpin with insulin-sensitizing effects. , 2008, Expert opinion on investigational drugs.

[49]  Janey L. Wiggs,et al.  Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice , 2002, Nature Genetics.

[50]  A. Schürmann,et al.  Subcellular fractionation of adipocytes and 3T3-L1 cells. , 2001, Methods in molecular biology.

[51]  E. Brunt.  Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.

[52]  Jie Xu,et al.  Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts , 2001, Journal of cellular biochemistry.

[53]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.